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ABSTRACT
ardiovascular disease (CVD) is a major cause of 
morbidity and premature death throughout Cthe world. The underlying pathology is 
atherosclerosis, which develops over many years and is 
usually advanced by the time symptoms occur, 
1
generally in middle age.  Acute coronary events (heart 
attack) and cerebrovascular events (stroke) frequently 
occur suddenly, and may be fatal before medical care 
2
can be given . Risk factor modification can reduce 
clinical events and premature death in people with 
established CVD as well as in those who are at high 
3-4
cardiovascular risk due to one or more risk factors.  To 
identify high risk patients without cardiovascular 
5-6
disease requires assessment of risk factors.  Obesity, 
the most  common nutrit ional  disorder in 
industrialized countries is associated with an increased 
7
mortality and morbidity of cardiovascular disease.  
Obesity is a chronic multifunctional and complex 
disease resulting from a long term positive energy 
balance, in which both genetic and environmental 
8
factors are involved.   Obesity is defined by body mass 
index (BMI) and further evaluated in terms of fat 
distribution via the waist–hip ratio and total 
9-10
cardiovascular risk factors.  
Body mass index is closely related to both percentage 
body fat and total body fat. The single or multiple risk 
factors that can predispose the individual to 
cardiovascular risk will be handled either by modified 
lifestyle or treatment with drugs, thereby reducing the 
incidence of cardiovascular disease. By decreasing 
blood pressure, cholesterol level, level of glycemia, 
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BACKGROUND: Risk factor modification can reduce clinical events and premature death in people with 
established cardiovascular disease (CVD) as well as in those who are at high cardiovascular risk due to one or more 
risk factors. Obesity, a common nutritional disorder in industrialized countries is associated with an increased 
mortality and morbidity of cardiovascular disease (CVD). 
OBJECTIVE: This study evaluated the CV risk factors in obesity and significance of obesity as a risk factor for 
acute coronary and cerebrovascular conditions which occur frequently in our society. 
METHOD: Cardiovascular risk assessment was carried out in 250 subjects, 125 obese and 125 non-obese   using 
the following methods: Framingham risk score, Gamma glutamy1 transferase, (GGT), CK-MB,  very high single risk 
factor (VHSRF) and more than 3 high risk factors (>3HRF)
RESULTS: With the different methods used for the assessment, percentage of individual at high risk tended to be 
higher in obese individual than in non obese, only Framingham Risk score method shows significant difference in 
risk percentage (P < 0.05). High blood pressure is the most predominant risk factor among the obese assessed 
(37.6%).  The mean value of all the variables (risk factor) except HDL were higher in obese subjects than non obese. 
Statistically, there were no significant differences between the means of FBG, HDL and GGT (P>0.05) whereas 
there were significant differences between the mean value of total cholesterol, LDL, VLDL, triglyceride, CK-MB and 
CRP (P<0.05). 
CONCLUSION: In conclusion, hypertension happens to be the most predominant cardiovascular risk factor 
observed among obese assessed. Obesity is a serious risk factor for cardiovascular disease because most 
cardiovascular disease risk factors assessed were  more predominant in obese  than in normal subjects  therefore 
reduction in weight of an individual is very important to reduce cardiovascular disease.    
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biochemically on 125 obese (test) and 125 non obese 
(control) with different methods shown below. The risk 
scores were stratified into low and high risk. 
Percentage of individuals at low risk was higher in both 
test and control than those at high risk as shown below.
Table 1:   Number and percentage (in bracket) of 
obese individual that are at LOW and HIGH risk of 
CVD using different methods of assessment  
Table 2: Number and percentages of non obese 
individual that are at low and high risk   of CVD 
using different methods for assessment 
It was observed that those  at high risk tends to be 
higher in obese subjects than in non obese although 
only Framingham Risk score method shows significant 
difference in risk percentage. (p < 0.05) as shown in 
figure 1 
proimflammatory cytokines and adhesion molecules, 
weight loss may prevent the progression of 
atherosclerosis or the occurrence of acute coronary 
syndrome event in the obese high risk population. 
Even after adjusting for risk factors, obesity remains 
11directly associated with CVD. 
Aim and objective: The aim of this study is to assess 
cardiovascular risk in obese individuals and to 
evaluate existing risk factor indices. The objectives of 
the study are (i) to measure lipid profile, C reactive 
protein (CRP), creatine kinase (CK-MB), fasting blood 
glucose (FBG), gamma glutamyl transferase (GGT); 
blood pressure (ii) to calculate risk factor indices; 
Reynold , Framingham risk score, blood pressure, very 
high single risk factor (VHSRF) and more than 3 high 
risk factors (>3HRF). (iii) to ascertain the predominant 
risk factor, sensitivity and specificity of the existing 
factors. This study aims at evaluating the significance 
of obesity as a risk factor for acute coronary and 
cerebrovascular conditions which occur frequently in 
our society.
Methodology
A cross  sectional study which involved a total of 250 
subjects, 125 obese and 125 non-obese was carried out 
in Awka and its environs. Ethical clearance was 
obtained from Ministry of Health, Anambra State 
Nigeria. Oral data collection was done using self 
administered close ended questionnaire with socio-
demographic characteristics, lifestyle and dietary 
habits, medical and family history. Anthropometric 
measurements weight, height and blood pressure  
4were taken according to WHO procedure.  Blood 
sample was collected from fasting subjects using 
standard procedure. Serum lipid profile, fasting blood 
glucose, CK-MB, GGT were estimated by automation 
using BS-120 Autoanalyser (Mindray), CRP 
concentration (hs-crp) was assayed by Enzyme-linked 
Immunosorbent Assay (ELISA) method using 
microplate reader 96 A (MR-96A) while cardiovascular 
risk assessment was carried out using the following 
methods: Framingham risk score, Gamma glutamy1 
transferase,  CK-MB,  very high single risk factor 
(VHSRF) and more than 3 high risk factors (>3HRF). 
The risk scores were stratified into low and high risk. 
Statistical analyses: Statistical analyses were done 
using Statistical package for social sciences  software 
(SPSS 17.0.)  Students't test was used to compare 
independent sample means; odd ratio and relative risk 
were used to access the methods. Statistical 
significance was set at p<0.05. 
RESULTS
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Table 4: Sensitivity and specificity table
Statistically, the mean values of all the variables 
analyzed were higher in obese than in non obese 
except HDL-C, there was no significant difference 
between the mean values of fasting blood glucose 
(FBG), HDL-C and Gamma Glutamyl transferase 
(GGT) (P> 0.05) whereas there was significant 
difference between the mean values of total 
cholesterol, LDL-C,VLDL-C, triglyceride, CK-MB 
and CRP (P <0.05) in obese and non-obese. 
Table 5:  Mean (±standard deviation) of risk factors 
analyzed in obese and control subjects
   p < 0.05 is significant, p < 0.001 is highly significant
The prevalence of CVD risk factors was relatively 
higher in obese than non obese. High blood pressure 
happens to be the most prevalent risk factor (37.6%) 
observed among obese individual assessed. Percentage 
of obese subject that have FBG >120mg/dl was 19%, 
total cholesterol > 235mg//dl was 24%, Systolic BP 
>140mm/Hg was 37.6%, LDL >135mg/dl (21.6%), 
CRP > 3mg/dl (32%), CK-MB > 24iu/L (17.6%), TG 
>155mg/dl (11%), GGT > 55 UI/L (19.2%) 
DISCUSSION
Obese and non obese individual were assessed for 
cardiovascular risk, and with the different methods 
used for the assessment, percentage of individuals at 
high risk tends to be higher in obese subjects than in 
non obese although only Framingham Risk score 
method shows significant difference in risk percentage. 
(p < 0.05) 
Fig 1:  Bar chart showing percentage of obese and non 
obese that are at high risk using different methods.
Reliability of these test method in diagnosing 
cardiovascular risk was assessed using odd ratio, 
proportion and relative risk. As proportion, odd ratio 
(OR) or relative risk (RR) increases, the likelihood of 
obese individual being more at high risk of CV 
increases. If OR > 1, then obese individual are more 
likely to be at high risk of cardiovascular disease using 
a particular method of assessment. All the methods 
showed OR, RR and proportion greater than 1. Reynold 
risk score method gave the highest OR and RR value. 
(OR = 5.88, RR = 2.60).  
Table 3: Reliability of test method in diagnosing 
cardiovascular risk (Odd ratio, proportion and 
relative risk)                                                                                                                            
Very High Risk Factor (VHRF) was the most sensitive 
method whereas Ck-MB was the most specific as 
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1.66 2.28 1.5
>3 HIGH RISK FACTOR 1.20 1.20 1.10
METHODS  FRAMINGHAM  REYNOLDS CK-
MB
GGT VHSRF >3HRF
         SENSITIVITY





10.4% 16.8% 48% 17.6%
SPECIFICITY 83.2% 86.4% 93.6% 89.6% 71.2% 84.8%
VARIABLE       OBESITY  CONTROL P-VALUE
FBG        108(± 48)  103(±51 ) P > 0.05
TOTAL CHOL
       
202(± 39)
 
185(±49 ) P < 0.05
LDL-C
       
117(±38 )
 
104(±39 ) P < 0.05
HDL-C
     
59.8(± 18 )
 
63.7(±17) P > 0.05
VLDL
       
24.5(±14)
 
17.8 (±10 ) P  < 0.001
TRIGLYCERIDE
      
122.7(±74)
 
88.4 (±50 ) P  < 0.001
CK-MB





14.1(±8.6) P  <  0.001
GGT 45.5(± 29 ) 44.9 (±41.7) P  > 0.05
CRP 2.97(± 2.5) 1.89(±2.2) P  < 0.001
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High sensitive CRP is a useful tool for early diagnosis of 
CV risk in obese children and adults. In this study, on 
using Reynolds risk score, 36% of obese and 13.6% non 
obese are at high risk of developing CVD and the mean 
serum hs-CRP level in obese is significantly greater 
than non obese. Higher BMI is associated with higher 
CRP concentration, even among young adults aged 17 
17.to 39years.  These findings suggest a state of low grade 
systemic inflammation in overweight and obese 
persons. Human adipose tissue expresses and releases 
the proinflammatory cytokine inducing low-grade 
18systemic inflammation in person with excess fat. . 
Heart patients who have persistent CRP between 4 and 
10mg/l, with clinical evidence of low grade 
inflammation should be considered to be at increased 
19risk of thrombosis.
In a report published in Circulation Journal of the 
American Heart Association, researchers cited Gamma 
glutammyl transferase test as one of the simplest ways 
to determine whether or not individuals are at risk of 
death from CVD. GGT method assessed 17% obese and 
10% non obese individual to be at risk in this study and 
the mean serum GGT level is higher in obese subject but 
there was no significant difference. This is in line with 
other studies which reported that high levels of GGT 
are associated with fatty liver, insulin resistance, type 2 
diabetes stroke, obesity and other metabolic risk 
20 factors.    Higher levels of GGT have been associated in 
20 population with increased risk of atherosclerosis.
Another important association between GGT and the 
metabolic Syndrome is the finding that higher GGT 
levels occur in obese particularly those with abdominal 
21obesity.  
CK_MB is a cardiac marker and can be used in 
diagnosis of myocardial infarction. High CK-MB is 
seen in acute myocardial infarction which rises in 4-
226hrs and reaches its peak at 18-24hrs after the attack.  In 
this study, 10% of obese and 7% non obese individual 
have high CK-MB level >24 IU/L but there was no 
significant difference in their percentage risk. The 
highest CK-MB level obtained in this study was 72 iu/l 
which is not so high. . Mean CK-MB level is 
significantly higher in obese individual than non obese 
(table 4.7). This method gave the least percentage of 
individual at CV risk and was most specific (93.6%). 
Limitation of CK-MB method of assessment is that high 
CK-MB is seen only after episodes of myocardial 
infarction which means that the individual has 
23   developed CVD (myocardial infarction) already. The 
pattern of serial CK-MB determination is more 
informative than a single determination. One CK MB 
measurement, even when taken at an appropriate time 
cannot definitely confirm or rule out the occurrence of 
24 acute myocardial infarction.   CK-MB is higher in 
obese non diabetic subject and lower in trained 
Individuals with a very high single risk factor showed 
highest percentage among both obese (48%) and non 
obese (28.8%), this shows that it is the most sensitive 
method. Any major risk factor, if left untreated for 
many years has the potential to produce CVD. This 
method is very useful because   single  risk factor 
detected  will be immediately modified by lifestyle or 
drug intervention thereby reducing chance of one 
having CVD. This is in line with report by the American 
Heart Association (AHA) which says that preventive 
12   effort should target each major risk factor. It was 
found that 18% obese and 15% non obese were at high 
risk of CVD on using >3HRF method. This is in line 
 11with work done by Lambert et al  which highlights 
high prevalence of multiple risk factors in a population 
based sample of overweight/obese in South Arabia. 
Considering the significant association between 
clustering of CVD risk factors and BMI or waist 
circumference, the study suggests that high prevalence 
of overweight may have important implications for the 
health care system, even at lower level of BMI or waist 
circumference.
In this study, on using FHS risk score method, 8.8% of 
obese and 4.8% of non obese shows high risk of CV. 
FHS has shortcomings in that it does not account for 
o ther  es tabl i shed major  r i sk  fac tors  l ike  
hypertriglyceridaemia, obesity, family history, 
inflammatory markers like CRP; there is emerging 
evidence in potentially using CRP, particularly using 
the Reynolds Risk score to reclassify intermediate risk 
13into a high risk category for potential intervention.   
Using Reynolds risk score, intermediate risk subject 
were reclassified to high risk subject giving 29% obese 
and 16.8% non- obese to be at high CV risk.  Of all the 
methods used, FHS method showed significant 
percentage risk difference between obese and non 
obese individual. This is because Framingham Heart 
study (FHS) has been in forefront of the development of 
cardiovascular risk prediction equations for 
assessment of absolute risk. Development of 
WHO/International society of Hypertension risk 
prediction chart have resulted in a paradigm shift in 
CVD prevention strategies, from a single risk factor to a 
more cost-effective total CV risk approach, an 
approach recommended by WHO for CVD prevention 
14worldwide.
There are instances when the tool overestimates risk in 
low-risk population and underestimates in high risk 
group. Recent studies have examined the accuracy of 
15FHS in women, different ethnic and social groups.  Its 
limitation is that they are not age specific but they are 
highly sensitive and specific. Work done by the Scottish 
MIDS PAN Data suggest that the exclusion of social 
deprivation and certain risk factors in the estimation of 
CV risk results in a serious underestimation of absolute 
15-16risk.
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contribute to body fat. 
Limitations of the study 
Limitations of this study include the small sample size 
and generalized study population.
CONCLUSION
High blood pressure was the most prevalent CVD risk 
factor observed among obese subjects. Obesity is a 
serious risk factor for CVD because most of the risk 
factors assessed were more prevalent in obese than in 
non obese subjects; therefore reduction in weight of an 
individual is very important to reduce the possibility of 
cardiovascular disease
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